Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Internal and Emergency Medicine
Published in: Internal and Emergency Medicine 2/2014

01-03-2014 | CE - LETTER TO THE EDITOR

Repeated systemic thromboembolism in a patient with severe cardiac AL amyloidosis without evidence of atrial fibrillation

Authors: Francesco Cappelli, Luigi Padeletti, Manlio Acquafresca, Alberto Moggi Pignone, Federico Perfetto

Published in: Internal and Emergency Medicine | Issue 2/2014

Login to get access

Excerpt

Systemic amyloidosis is a disease in which amyloidogenic precursor proteins accumulate as insoluble fibrils on several vital organs, ultimately leading to fatal multi-organ failure. The heart is commonly involved in the majority of patients with amyloidosis, occasionally producing arterial thromboembolism as a complication [1]. We present a case of repeated systemic arterial thromboembolism in a patient with severe AL (primary) cardiac amyloidosis and no evidence of atrial fibrillation (AF). …
Literature
1.
Nakagawa M, Tojo K, Sekijima Y, Yamazaki KH, Ikeda S (2012) Arterial thromboembolism in senile systemic amyloidosis: report of two cases. Amyloid 19(2):118–121PubMedCrossRef
2.
Perfetto F, Cappelli F, Bergesio F, Ciuti G, Porciani MC, Padeletti L, Moggi Pignone A (2013) Cardiac amyloidosis: the heart of the matter. Intern Emerg Med 8(3):191–203
3.
Dubrey S, Pollak A, Skinner M, Falk RH (1995) Atrial thrombi occurring during sinus rhythm in cardiac amyloidosis: evidence for atrial electromechanical dissociation. Br Heart J 74:541–544PubMedCentralPubMedCrossRef
4.
Feng D, Edwards WD, Oh JK, Chandrasekaran K, Grogan M, Martinez MW, Syed IS, Hughes DA, Lust JA, Jaffe AS, Gertz MA, Klarich KW (2007) Intracardiac thrombosis and embolism in patients with cardiac amyloidosis. Circulation 116(21):2420–2426PubMedCrossRef
5.
Zubkov AY, Rabinstein AA, Dispenzieri A, Wijdicks EF (2007) Primary systemic amyloidosis with ischemic stroke as a presenting complication. Neurology 69(11):1136–1141PubMedCrossRef
6.
Berghoff M, Kathpal M, Khan F, Skinner M, Falk R, Freeman R (2003) Endothelial dysfunction precedes C-fiber abnormalities in primary (AL) amyloidosis. Ann Neurol 53:725–730PubMedCrossRef
7.
Gamba G, Montani N, Anesi E, Palladini G, Lorenzutti F, Perfetti V, Merlini G (1999) Abnormalities in thrombin-antithrombin pathway in AL amyloidosis. Amyloid 6(4):273–277PubMedCrossRef
Metadata
Title
Repeated systemic thromboembolism in a patient with severe cardiac AL amyloidosis without evidence of atrial fibrillation
Authors
Francesco Cappelli
Luigi Padeletti
Manlio Acquafresca
Alberto Moggi Pignone
Federico Perfetto
Publication date
01-03-2014
Publisher
Springer Milan
Published in
Internal and Emergency Medicine / Issue 2/2014
Print ISSN: 1828-0447
Electronic ISSN: 1970-9366
DOI
https://doi.org/10.1007/s11739-013-0960-8

Other articles of this Issue 2/2014

Internal and Emergency Medicine 2/2014 Go to the issue

IM - REVIEW

Is there a clinical role for oxidative stress biomarkers in atherosclerotic diseases?

CE - LETTER TO THE EDITOR

Leg paralysis due to herpes zoster: segmental paralysis or viral vasculopathy and stroke?

IM - ORIGINAL

Lung ultrasound in the diagnosis of stroke-associated pneumonia

CE - MEDICAL ILLUSTRATION

A hidden echocardiographic pitfall: the Gerbode defect

IM - REVIEW

Carotid stenosis management: a review for the internist

CE-HEALTH TECHNOLOGY ASSESSMENT

Bridge with intravenous antiplatelet therapy during temporary withdrawal of oral agents for surgical procedures: a systematic review
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits